Javier Aspa

2.9k total citations
55 papers, 1.8k citations indexed

About

Javier Aspa is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Javier Aspa has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 10 papers in Critical Care and Intensive Care Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Javier Aspa's work include Pneumonia and Respiratory Infections (36 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers) and Respiratory viral infections research (12 papers). Javier Aspa is often cited by papers focused on Pneumonia and Respiratory Infections (36 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers) and Respiratory viral infections research (12 papers). Javier Aspa collaborates with scholars based in Spain, United States and Mexico. Javier Aspa's co-authors include Felipe Rodrı́guez de Castro, Olga Rajas, Rosario Menéndez, Luis Borderías, José Blanquer, Rafael Zalacaín, Antoni Torres, José María Galván‐Román, Antoní Torres and Alberto Capelastegui and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Javier Aspa

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Aspa Spain 24 1.2k 353 300 290 253 55 1.8k
Beatriz Rosón Spain 21 1.2k 1.0× 296 0.8× 373 1.2× 93 0.3× 114 0.5× 47 2.2k
Esa Rintala Finland 27 762 0.7× 188 0.5× 183 0.6× 245 0.8× 265 1.0× 66 2.1k
José Blanquer Spain 25 1.1k 1.0× 339 1.0× 349 1.2× 40 0.1× 245 1.0× 63 1.7k
Eyal Robenshtok Israel 27 812 0.7× 128 0.4× 163 0.5× 288 1.0× 73 0.3× 92 2.6k
Lauren M. Simon United States 6 872 0.8× 156 0.4× 291 1.0× 88 0.3× 121 0.5× 21 1.5k
Martin E. Doerfler United States 18 556 0.5× 152 0.4× 195 0.7× 67 0.2× 489 1.9× 36 1.5k
Stefanos Geroulanos Greece 18 471 0.4× 202 0.6× 231 0.8× 67 0.2× 182 0.7× 70 1.5k
Olga Rajas Spain 20 689 0.6× 311 0.9× 94 0.3× 64 0.2× 210 0.8× 44 1.1k
Ivan Le Jeune United Kingdom 11 1.0k 0.9× 973 2.8× 283 0.9× 84 0.3× 45 0.2× 17 2.1k
Dominique J. Pepper South Africa 24 1.1k 0.9× 115 0.3× 116 0.4× 120 0.4× 91 0.4× 39 1.9k

Countries citing papers authored by Javier Aspa

Since Specialization
Citations

This map shows the geographic impact of Javier Aspa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Aspa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Aspa more than expected).

Fields of papers citing papers by Javier Aspa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Aspa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Aspa. The network helps show where Javier Aspa may publish in the future.

Co-authorship network of co-authors of Javier Aspa

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Aspa. A scholar is included among the top collaborators of Javier Aspa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Aspa. Javier Aspa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐Fleta, Pedro, Celeste Marcos, Daniel Jiménez‐Carretero, et al.. (2024). Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID. Clinical Immunology. 264. 110267–110267. 1 indexed citations
2.
Rogado, Jacobo, Fernando Campo del Pozo, Kevin Troulé, et al.. (2022). Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC. Cancers. 14(12). 2898–2898. 8 indexed citations
3.
Martínez‐Fleta, Pedro, Silvia Requena, Emilia Roy‐Vallejo, et al.. (2022). A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19. Frontiers in Immunology. 12. 815651–815651. 34 indexed citations
4.
Rogado, Jacobo, J.M. Sánchez-Torres, Nuria Romero-Laorden, et al.. (2019). Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. European Journal of Cancer. 109. 21–27. 192 indexed citations
5.
Curbelo, José, José María Galván‐Román, Olga Rajas, et al.. (2017). Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLoS ONE. 12(3). e0173947–e0173947. 119 indexed citations
6.
Menéndez, Rosario, Beatriz Montull, Soledad Reyes, et al.. (2016). Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome. Journal of Infection. 73(5). 419–426. 23 indexed citations
7.
Rajas, Olga, José María Galván‐Román, José Curbelo, et al.. (2014). The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers. BMC Pulmonary Medicine. 14(1). 197–197. 7 indexed citations
8.
Fuentes, José M., et al.. (2013). Mesa redonda 2. Papel del hospital en la formación en investigación. 16. 21–37.
9.
García-Laorden, M. Isabel, Felipe Rodrı́guez de Castro, Jordi Solé‐Violán, et al.. (2012). The role of mannose-binding lectin in pneumococcal infection. European Respiratory Journal. 41(1). 131–139. 33 indexed citations
10.
Solé‐Violán, Jordi, M. Isabel García-Laorden, Felipe Rodrı́guez de Castro, et al.. (2011). The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia*. Critical Care Medicine. 39(6). 1388–1393. 38 indexed citations
11.
Menéndez, Rosario, Antoni Torres, S. Reyes, et al.. (2011). Initial management of pneumonia and sepsis: factors associated with improved outcome. European Respiratory Journal. 39(1). 156–162. 59 indexed citations
12.
Martín‐Loeches, Ignacio, Jordi Solé‐Violán, Felipe Rodrı́guez de Castro, et al.. (2011). Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia. Intensive Care Medicine. 38(2). 256–262. 53 indexed citations
13.
Castro, Felipe Rodrı́guez de, Jordi Solé‐Violán, Olga Rajas, et al.. (2011). Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study. Critical Care. 15(1). R57–R57. 40 indexed citations
14.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2008). Risk Factors for Multidrug-Resistant Pneumococcal Pneumonia. Infectious Diseases in Clinical Practice. 16(6). 368–375.
15.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2006). Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. European Respiratory Journal. 27(5). 1010–1019. 62 indexed citations
16.
Menéndez, Rosario, Antoni Torres, Rafael Zalacaín, et al.. (2005). Guidelines for the Treatment of Community-acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 172(6). 757–762. 118 indexed citations
17.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2004). Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors. Clinical Infectious Diseases. 38(6). 787–798. 96 indexed citations
18.
Zalacaín, Rafael, Antoni Torres, Raquel Celis, et al.. (2003). Community-acquired pneumonia in the elderly: Spanish multicentre study. European Respiratory Journal. 21(2). 294–302. 96 indexed citations
19.
20.
Aspa, Javier, B. Padilla, Julio Ancochea, et al.. (1991). Fiberoptic bronchoscopic diagnosis of pulmonary disease in 151 HIV-infected patients with pneumonitis. European Journal of Clinical Microbiology & Infectious Diseases. 10(6). 491–496. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Rosón Breakdown of academic impact, for papers by Esa Rintala Breakdown of academic impact, for papers by José Blanquer Breakdown of academic impact, for papers by Eyal Robenshtok Breakdown of academic impact, for papers by Lauren M. Simon Breakdown of academic impact, for papers by Martin E. Doerfler Breakdown of academic impact, for papers by Stefanos Geroulanos Breakdown of academic impact, for papers by Olga Rajas Breakdown of academic impact, for papers by Ivan Le Jeune Breakdown of academic impact, for papers by Dominique J. Pepper
Rankless by CCL
2026